No Data
No Data
No Data
No Data
No Data
Jupiter Neurosciences, Inc. Announces Research Breakthrough With JOTROL™ in Parkinson's Disease
JUPITER, Fla. and BOSTON, Feb. 27, 2023 /PRNewswire/ -- Jupiter Neurosciences, Inc. ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline focused on the treatment of
PR NewswireFeb 27, 2023 21:45
Jupiter Neurosciences, Inc. Announces Appointment of New Chief Financial Officer
JUPITER, Fla. and BOSTON, Jan. 12, 2023 /PRNewswire/ -- Jupiter Neurosciences, Inc. ("JUPITER" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline focused on the treatment of
PR NewswireJan 12, 2023 21:46
Jupiter Neurosciences Expects to Offer 2.6M Shrs in IPO; For Purposes of Prospectus, Assumed Price Is $5.75 Each
Jupiter Neurosciences Expects to Offer 2.6M Shrs in IPO; For Purposes of Prospectus, Assumed Price Is $5.75 Each
Dow JonesDec 3, 2022 07:02
US stock IPO forecast for this week: 5 IPOs to be listed, 2 are likely
This week's IPOs include 2 Chinese securities — Ricon China (LICN) and Material Core Technology (WXT).
美股百科Sep 20, 2022 10:53
Jupiter Neurosciences, Inc. Prices IPO at $5.00-$7.00 Per Share (JUNS)
Jupiter Neurosciences, Inc. (JUNS) is planning to raise $15 million in an IPO on Wednesday, September 21st, IPO Scoop reports. The company plans to issue 2,500,000 shares at $5.00-$7.00 per share. S
Defense WorldSep 17, 2022 13:21
Catalyst Watch: Eyes On Nvidia, Salesforce, Rocket Lab, Rumble and Qualcomm
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events
Seeking AlphaSep 17, 2022 03:35
No Data
No Data